The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

被引:51
作者
Khezri, Mohammad Rafi [1 ]
Jafari, Reza [2 ]
Yousefi, Keyvan [3 ]
Zolbanin, Naime Majidi [4 ,5 ,6 ]
机构
[1] Urmia Univ Med Sci, Student Res Comm, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Cellular & Mol Med Inst, Cellular & Mol Res Ctr, Orumiyeh, Iran
[3] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33146 USA
[4] Urmia Univ Med Sci, Expt & Appl Pharmaceut Sci Res Ctr, Orumiyeh, Iran
[5] Urmia Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Orumiyeh, Iran
[6] Urmia Univ Med Sci, Sch Fac Pharm, Dept Pharmacol & Toxicol, Sero Rd, Orumiyeh, Iran
关键词
Angiogenesis; Apoptosis; Cancer; PI3K; AKT; CELL LUNG-CANCER; INHIBITS TUMOR ANGIOGENESIS; GROWTH-FACTOR RECEPTOR; I KAPPA B; BREAST-CANCER; GASTRIC-CANCER; OVARIAN-CANCER; PANCREATIC-CANCER; UP-REGULATION; COLON-CANCER;
D O I
10.1016/j.yexmp.2022.104787
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The human body consists of countless cells with the possibility of excessive and uncontrolled proliferation under certain dysregulated circumstances that could cause abnormal states such as cancer. Phosphatidylinositol 3 kinase (PI3K) and its downstream target, Protein kinase B or AKT, play a critical role in cell survival, proliferation, differentiation, migration, and metabolism. Research studies have examined the aberrant expression of signaling molecules that regulate PI3K/AKT pathway with the purpose of target discovery. The present review aims to recapitulate the relationship between the PI3K/AKT signaling pathway and factors contributing to initiation and development of various cancers. In addition, therapeutic interventions regulating this signaling pathway have been summarized.
引用
收藏
页数:12
相关论文
共 200 条
  • [1] PI3K/Akt-mediated regulation of p53 in cancer
    Abraham, Aswin G.
    O'Neill, Eric
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 798 - 803
  • [2] Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha
    Alessi, DR
    James, SR
    Downes, CP
    Holmes, AB
    Gaffney, PRJ
    Reese, CB
    Cohen, P
    [J]. CURRENT BIOLOGY, 1997, 7 (04) : 261 - 269
  • [3] PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
    Alqahtani, Ali
    Ayesh, Hazem S. K.
    Halawani, Hafez
    [J]. CANCERS, 2020, 12 (01)
  • [4] Ataie-Kachoie P, 2015, AM J CANCER RES, V5, P575
  • [5] AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
    Azzalini, Eros
    Tierno, Domenico
    Bartoletti, Michele
    Barbazza, Renzo
    Giorda, Giorgio
    Puglisi, Fabio
    Cecere, Sabrina Chiara
    Losito, Nunzia Simona
    Russo, Daniela
    Stanta, Giorgio
    Canzonieri, Vincenzo
    Bonin, Serena
    [J]. CANCERS, 2022, 14 (02)
  • [6] Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma
    Babae, Negar
    Bourajjaj, Meriem
    Liu, Yijia
    Van Beijnum, Judy R.
    Cerisoli, Francesco
    Scaria, Puthupparampil V.
    Verheul, Mark
    Van Berkel, Maaike P.
    Pieters, Ebel H. E.
    Van Haastert, Rick J.
    Yousefi, Afrouz
    Mastrobattista, Enrico
    Storm, Gert
    Berezikov, Eugene
    Cuppen, Edwin
    Woodle, Martin
    Schaapveld, Roel Q. J.
    Prevost, Gregoire P.
    Griffioen, Arjan W.
    Van Noort, Paula I.
    Schiffelers, Raymond M.
    [J]. ONCOTARGET, 2014, 5 (16) : 6687 - 6700
  • [7] Akt Isoforms: A Family Affair in Breast Cancer
    Basu, Alakananda
    Lambring, Christoffer Briggs
    [J]. CANCERS, 2021, 13 (14)
  • [8] Biaglow JE, 2005, CANCER BIOL THER, V4, P6
  • [9] Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator
    Bin Hafeez, Bilal
    Adhami, Vaqar Mustafa
    Asim, Mohammad
    Siddiqui, Imtiaz A.
    Bhat, Kumar M.
    Zhong, Weixiong
    Saleem, Mohammad
    Din, Maria
    Setaluri, Vijayasaradhi
    Mukhtar, Hasan
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (02) : 452 - 459
  • [10] PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement
    Bonin, S.
    Pracella, D.
    Barbazza, R.
    Dotti, I.
    Boffo, S.
    Stanta, G.
    [J]. DISEASE MARKERS, 2019, 2019